BG104332A - 2-substituted 1,2-benzisothiazole derivayives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) - Google Patents

2-substituted 1,2-benzisothiazole derivayives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Info

Publication number
BG104332A
BG104332A BG104332A BG10433200A BG104332A BG 104332 A BG104332 A BG 104332A BG 104332 A BG104332 A BG 104332A BG 10433200 A BG10433200 A BG 10433200A BG 104332 A BG104332 A BG 104332A
Authority
BG
Bulgaria
Prior art keywords
alkyl
branched
substituted
unbranched
phenyl
Prior art date
Application number
BG104332A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wilfried Lubisch
Uta Dullweber
Dorothea Starck
Gerd Steiner
Alfred Bach
Franz Emling
Xavier Garcia-Ladona
Hans-Juergen Teschendorf
Karsten Wicke
Original Assignee
Basf Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Aktiengesellschaft filed Critical Basf Aktiengesellschaft
Publication of BG104332A publication Critical patent/BG104332A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BG104332A 1997-10-22 2000-04-11 2-substituted 1,2-benzisothiazole derivayives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d) BG104332A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19746612A DE19746612A1 (de) 1997-10-22 1997-10-22 2-Substituierte 1,2-Benzisothiazol-Derivate, ihre Herstellung und Verwendung
PCT/EP1998/006300 WO1999020616A1 (fr) 1997-10-22 1998-10-05 Derives de 1,2-benzisothiazol 2-substitues, leur preparation et leur utilisation comme antagonistes de la serotonine (5-ht1a, 5-ht1b et 5-ht1d)

Publications (1)

Publication Number Publication Date
BG104332A true BG104332A (en) 2001-02-28

Family

ID=7846266

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104332A BG104332A (en) 1997-10-22 2000-04-11 2-substituted 1,2-benzisothiazole derivayives and their use as serotonin antagonists (5-ht1a, 5-ht1b and 5-ht1d)

Country Status (23)

Country Link
US (1) US6346622B1 (fr)
EP (1) EP1034170A1 (fr)
JP (1) JP2001520224A (fr)
KR (1) KR20010031297A (fr)
CN (1) CN1277607A (fr)
AR (1) AR016968A1 (fr)
AU (1) AU748613B2 (fr)
BG (1) BG104332A (fr)
BR (1) BR9812948A (fr)
CA (1) CA2307199A1 (fr)
CO (1) CO4980863A1 (fr)
DE (1) DE19746612A1 (fr)
HR (1) HRP980555A2 (fr)
HU (1) HUP0003758A3 (fr)
IL (1) IL135256A0 (fr)
NO (1) NO20001937D0 (fr)
NZ (1) NZ503604A (fr)
PL (1) PL340033A1 (fr)
SK (1) SK4572000A3 (fr)
TR (1) TR200001080T2 (fr)
TW (1) TW517052B (fr)
WO (1) WO1999020616A1 (fr)
ZA (1) ZA989571B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19900544A1 (de) * 1999-01-11 2000-07-13 Basf Ag Verwendung von Verbindungen der Formel I zur Prophylaxe und Therapie der zerebralen Ischämie
EA200500342A1 (ru) * 2002-09-17 2005-08-25 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл-Эл-Си Гетероциклические замещённые пиперазины для лечения шизофрении
US20040127501A1 (en) * 2002-09-24 2004-07-01 Zhengming Chen Therapeutic agents useful for treating pain
ES2350977T3 (es) 2002-11-05 2011-01-28 Glaxo Group Limited Agentes antibacterianos.
KR100472988B1 (ko) 2002-11-27 2005-03-10 씨제이 주식회사 조직감, 취반성 및 안전성이 우수한 발아 현미의 제조방법및 이로부터 얻은 발아 현미
CN101151249B (zh) * 2005-03-31 2011-04-06 辉瑞产品公司 环戊吡啶及四氢喹啉衍生物
EP3617194B1 (fr) * 2008-12-11 2023-11-08 VIIV Healthcare Company Procédés et intermédiaires pour inhibiteurs de l'intégrase du vih de carbamoylpyridone
WO2020183011A1 (fr) 2019-03-14 2020-09-17 Institut Curie Inhibiteurs de htr1d et leurs utilisations dans le traitement du cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8601494A (nl) 1985-06-22 1987-01-16 Sandoz Ag Thiazolen, hun bereiding en farmaceutische preparaten die ze bevatten.
DE3620643A1 (de) * 1985-06-22 1987-01-22 Sandoz Ag Thiazole, ihre herstellung und verwendung
FR2662696A1 (fr) 1989-12-13 1991-12-06 Rhone Poulenc Sante Antagonistes de la serotonine, leur preparation et medicaments les contenant.
FR2675800A1 (fr) * 1991-04-26 1992-10-30 Rhone Poulenc Rorer Sa Derives heterocycliques antiserotonines leur preparation et les medicaments les contenant.
JPH0912562A (ja) 1995-06-22 1997-01-14 Suntory Ltd 置換ベンゾチアジン誘導体

Also Published As

Publication number Publication date
HUP0003758A1 (hu) 2001-10-28
BR9812948A (pt) 2000-08-08
TR200001080T2 (tr) 2001-01-22
KR20010031297A (ko) 2001-04-16
DE19746612A1 (de) 1999-04-29
WO1999020616A1 (fr) 1999-04-29
CO4980863A1 (es) 2000-11-27
ZA989571B (en) 2000-04-25
NZ503604A (en) 2002-03-01
EP1034170A1 (fr) 2000-09-13
SK4572000A3 (en) 2000-10-09
HRP980555A2 (en) 1999-08-31
CN1277607A (zh) 2000-12-20
TW517052B (en) 2003-01-11
PL340033A1 (en) 2001-01-15
NO20001937L (no) 2000-04-13
NO20001937D0 (no) 2000-04-13
US6346622B1 (en) 2002-02-12
JP2001520224A (ja) 2001-10-30
IL135256A0 (en) 2001-05-20
AR016968A1 (es) 2001-08-01
HUP0003758A3 (en) 2001-12-28
AU1149799A (en) 1999-05-10
CA2307199A1 (fr) 1999-04-29
AU748613B2 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
YU68896A (sh) Jedinjenja hinolina i nihazolina od koristi u terapiji
HUP9901535A2 (hu) Aril-pirimidin-származékok, eljárás előállításukra és ezeket tartalmazó gyógyszerkészítmények
TR200103273T2 (tr) Hemisentetik yöntem ve yeni bileşimler.
BR9910326A (pt) Processo para preeparar isoxazóis, composto, processo para preparar compostos, uso de compostos, e, processo para preparar tioéteres
BG103560A (en) Quinoline and quinazoline compounds applicable in medicine, in particular for the treatment of benignant prostate hyperplasia
HUP0401461A2 (hu) 1-Fenilszulfonil-1,3-dihidro-2H-indol-2-on-származékok, a vegyületek előállítása és terápiás alkalmazása
KR930017900A (ko) 벤즈이미다졸릴 유도체, 이 화합물을 함유하는 약제학적 조성물 및 이의 제조방법
Nasir et al. Inhibition of lipid peroxidation mediated by indolizines
AR002011A1 (es) Compuestos derivados de piperidina, sus sales y n-oxidos, procedimiento de preparacion y composiciones farmaceuticas.
AR007077A1 (es) Derivados tetrahidroisoquinolina, un procedimiento para su preparacion, una composicion farmaceutica que los contiene, el uso de los mismos parala fabricacion de un medicamento
ATE255563T1 (de) Therapeutisch nützliche chinoline und quinazoline
ATE252575T1 (de) Indole und 2,3-dihydroindolderivate, ihre herstellung und verwendung
NZ233752A (en) Substituted quinoline derivatives, preparation and pharmaceutical compositions thereof
FI955661A0 (fi) Substituoidut beta-aryyli- ja beta-heteroaryyli-alfa-syanoakryyliamidijohdannaiset tyrosiinikinaasi-inhibiittoreina
HUP0003155A2 (hu) Eljárás COX-2 inhibitorként alkalmazható 2-aril-3-aril-5-halogénpiridin-származékok előállítására
HRP20000878B1 (hr) Kemijska sinteza derivata morfolina
Clark et al. Synthetic studies on the lithiated toluamide-imine cycloaddition route to (.+-.)-corydalic acid methyl ester
KR970006302A (ko) 4-아미노-3-아실나프티리딘 유도체
HUP9602763A2 (hu) 3-Fenil-izoxazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyászati készítmények
MXPA04003278A (es) Derivados de 5-metoxi-8-aril-?1,2,4?triazolo?1,5-a?piridina como antagonistas del receptor de adenosina.
PE20010649A1 (es) Derivados de antranilamida de piperidinas 1,4-di-sustituidas como antagonistas muscarinicos
DE3786109D1 (de) Pyrido(2,3-d)pyrimidin-derivate.
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
Beccalli et al. An alternative approach to the synthesis of functionalized pyrido [2, 3-b] indoles
PT1430034E (pt) Derivados de alquilaminopiridazinona substituida processo para sua preparacao e composicoes farmaceuticas que os contem